Christine Emnett, PhD
Christine Emnett, PhD
Biography
Christine Emnett's practice focuses on patent preparation and prosecution in the life sciences and biotechnology sectors. Leveraging her technical background in biomedical sciences, Christine has handled matters involving gene editing, antibodies and other biologics, immunotherapies, cell therapies, nucleic acids and vectors, biomarkers, detection assays and related technologies. She also performs patentability searches as well as freedom to operate (FTO) and landscape analysis. She has advised small to multinational clients in the biotechnology space.
Professional experience
Education
Education
- PhD, Biological and Biomedical Sciences – Neurosciences, Washington University in St. Louis, 2014
- BS, Biochemistry, summa cum laude, Mount Saint Mary’s University, 2009
Christine was registered in 2017 with United States Patent and Trademark Office (USPTO).
Admissions
Admissions
- US Patent and Trademark Agent
Publications
Publications
- First author, “Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel,” British Journal of Pharmacology, March 2015
- First author, "Electrophysiology of Neurons," Neural Stem Cell Assays (2014): 179-187
- First author, “Indistinguishable synaptic pharmacodynamics of the N-methyl-D-aspartate receptor channel blockers memantine and ketamine,” Molecular Pharmacology, December 2013
- First author*, “Synaptic NMDA receptors mediate hypoxic excitotoxic death,” Journal of Neuroscience, May 2012 (*published under maiden name)
Insights and news
Subscribe to our insights
Stay up to date with the latest publications, podcasts, webinars and events